 |
|
Ocular Tuberculosis
Matthew J. Thompson, MD;
Daniel M. Albert, MD, MS
Arch Ophthalmol. 2005;123:844-849.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
This month the Archives of Ophthalmology joins with JAMA in focusing on tuberculosis for their theme issue. Tuberculosis remains the world’s leading infectious cause of death and can also cause a variety of diseases throughout the body and the eye.1 Worldwide there are approximately 8 million new cases and 3 million deaths from tuberculosis each year.2-3 Approximately one third of the world’s population has been infected.3 The demographics of infection vary widely, with developing countries bearing the heaviest burden of disease.
In the United States in 1953, the annual risk of being infected with tuberculosis was 53 per 100 000 members of the population. This decreased to 9.4 per 100 000 by 1984, and the World Health Organization set a goal of eliminating tuberculosis worldwide. There was a resurgence in the United States to a peak of 10.5 per 100 000 by 19924-5; . . . [Full Text of this Article]
EFFECT OF HUMAN IMMUNODEFICIENCY VIRUS ON TUBERCULOSIS AND OCULAR TUBERCULOSIS
CLINICAL FEATURES OF INFECTION
Eyelids and Conjunctiva Cornea Sclera Uvea and Uveitis Choroid Retina Orbit Endophthalmitis Neuro-ophthalmologic Disease
DIAGNOSIS OF TUBERCULOSIS IN VARIOUS TISSUES
TREATMENT OF TUBERCULOSIS
OCULAR ADVERSE EFFECTS OF ANTITUBERCULOUS DRUGS
AUTHOR INFORMATION
Author Affiliations: Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison.
|
